CAMBRIDGE, Mass., Nov. 6, 2014 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will webcast its presentation at three upcoming investor conferences.
2014 Credit Suisse Healthcare Conference
Wednesday, November 12 at 1:30 p.m. ET in Phoenix, AZ
Stifel 2014 Healthcare Conference
Wednesday, November 19, 2014 at 8:35 a.m. ET in New York, NY
Goldman Sachs US Emerging / SMID Cap Growth Conference
Thursday, November 20, 2014 at 8:10 a.m. ET in New York, NY
The audio webcast of the presentation will be available live on the "Investors" section of the company's website located at www.momentapharma.com. A replay of the presentation will be posted on the Momenta website approximately one hour after the event and will be available for two weeks following the presentation.
Momenta Pharmaceuticals is a biotechnology company specializing in the detailed structural analysis of complex drugs and is headquartered in Cambridge, MA. Momenta is applying its technology to the development of generic versions of complex drugs, biosimilar and potentially interchangeable biologics, and to the discovery and development of novel therapeutics for oncology and autoimmune indications.
To receive additional information about Momenta, please visit the website at www.momentapharma.com, which does not form a part of this press release.
Our logo, trademarks, and service marks are the property of Momenta Pharmaceuticals, Inc. All other trade names, trademarks, or service marks are property of their respective owners.
CONTACT: Momenta Pharmaceuticals, Inc. firstname.lastname@example.orgSource:Momenta Pharmaceuticals